Liu X, Cheng X, Xie F, Li K, et al. Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer. Br J Cancer 2024 Mar 22. doi: 10.1038/s41416-024-02610.
PMID: 38519706